{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:21:32Z","timestamp":1792113692866,"version":"4.4.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07446-7","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T08:35:40Z","timestamp":1765269340000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["IL-1\u03b2\u2013induced STAT3 activation drives IL-17\u2013producing CD8+ tissue-resident memory T cells and exacerbates chronic psoriasis"],"prefix":"10.1186","volume":"24","author":[{"given":"TaeHo","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae Rim","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon-Yeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Ram.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Joon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5715-3989","authenticated-orcid":false,"given":"Chul Hwan","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-La","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"7446_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J. Psoriasis. Lancet. 2021;397:1301\u201315.","journal-title":"Psoriasis. Lancet"},{"key":"7446_CR2","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1001\/jamadermatol.2019.0315","volume":"155","author":"CH Bang","year":"2019","unstructured":"Bang CH, Yoon JW, Chun JH, Han JH, Park YM, Lee SJ, Lee JH. Association of psoriasis with mental health disorders in South Korea. JAMA Dermatol. 2019;155:747\u201349.","journal-title":"JAMA Dermatol"},{"key":"7446_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-025-00630-5","volume":"11","author":"AW Armstrong","year":"2025","unstructured":"Armstrong AW, Blauvelt A, Callis Duffin K, Huang YH, Savage LJ, Guo L, Merola JF. Psoriasis. Nat Rev Dis Primers. 2025;11:45.","journal-title":"Nat Rev Dis Primers"},{"key":"7446_CR4","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","volume":"8","author":"J Guo","year":"2023","unstructured":"Guo J, Zhang H, Lin W, Lu L, Su J, Chen X. Signaling pathways and targeted therapies for psoriasis. Signal Transduct Target Ther. 2023;8:437.","journal-title":"Signal Transduct Target Ther"},{"key":"7446_CR5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jid.2018.07.025","volume":"139","author":"Y Cai","year":"2019","unstructured":"Cai Y, Xue F, Quan C, Qu M, Liu N, Zhang Y, Fleming C, Hu X, Zhang HG, Weichselbaum R, et al. A critical role of the IL-1beta-IL-1R signaling pathway in skin inflammation and psoriasis pathogenesis. The J Invest Dermatol. 2019;139:146\u201356.","journal-title":"The J Invest Dermatol"},{"key":"7446_CR6","doi-asserted-by":"crossref","unstructured":"Nakamizo S, Dutertre CA, Khalilnezhad A, Zhang XM, Lim S, Lum J, Koh G, Foong C, Yong PJA, Tan KJ, et al. Single-cell analysis of human skin identifies CD14+ type 3 dendritic cells co-producing IL1B and IL23A in psoriasis. J Exp Med. 2021;218.","DOI":"10.1084\/jem.20202345"},{"key":"7446_CR7","doi-asserted-by":"publisher","first-page":"15790","DOI":"10.1074\/jbc.RA118.002721","volume":"293","author":"SK Whitley","year":"2018","unstructured":"Whitley SK, Balasubramani A, Zindl CL, Sen R, Shibata Y, Crawford GE, Weathington NM, Hatton RD, Weaver CT. IL-1R signaling promotes STAT3 and NF-kappaB factor recruitment to distal cis-regulatory elements that regulate Il17a\/f transcription. J Biol Chem. 2018;293:15790\u2013800.","journal-title":"J Biol Chem"},{"key":"7446_CR8","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.0022-202X.2004.22305.x","volume":"122","author":"J Shepherd","year":"2004","unstructured":"Shepherd J, Little MC, Nicklin MJ. Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist. The J Invest Dermatol. 2004;122:665\u201369.","journal-title":"The J Invest Dermatol"},{"key":"7446_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1146\/annurev-immunol-101320-020220","volume":"42","author":"SN Christo","year":"2024","unstructured":"Christo SN, Park SL, Mueller SN, Mackay LK. The multifaceted role of tissue-resident memory T cells. Annu Rev Immunol. 2024;42:317\u201345.","journal-title":"Annu Rev Immunol"},{"key":"7446_CR10","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.it.2021.08.002","volume":"42","author":"K Yang","year":"2021","unstructured":"Yang K, Kallies A. Tissue-specific differentiation of CD8(+) resident memory T cells. Trends Immunol. 2021;42:876\u201390.","journal-title":"Trends Immunol"},{"key":"7446_CR11","doi-asserted-by":"publisher","first-page":"eadd8454","DOI":"10.1126\/sciimmunol.add8454","volume":"8","author":"R Tieu","year":"2023","unstructured":"Tieu R, Zeng Q, Zhao D, Zhang G, Feizi N, Manandhar P, Williams AL, Popp B, Wood-Trageser MA, Demetris AJ, et al. Tissue-resident memory T cell maintenance during antigen persistence requires both cognate antigen and interleukin-15. Sci Immunol. 2023;8:eadd8454.","journal-title":"Sci Immunol"},{"key":"7446_CR12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41586-024-08466-x","volume":"639","author":"M Reina-Campos","year":"2025","unstructured":"Reina-Campos M, Monell A, Ferry A, Luna V, Cheung KP, Galletti G, Scharping NE, Takehara KK, Quon S, Challita PP, et al. Tissue-resident memory CD8 T cell diversity is spatiotemporally imprinted. Nature. 2025;639:483\u201392.","journal-title":"Nature"},{"key":"7446_CR13","doi-asserted-by":"publisher","first-page":"eabq3254","DOI":"10.1126\/sciimmunol.abq3254","volume":"7","author":"SK Whitley","year":"2022","unstructured":"Whitley SK, Li M, Kashem SW, Hirai T, Igyarto BZ, Knizner K, Ho J, Ferris LK, Weaver CT, Cua DJ, et al. Local IL-23 is required for proliferation and retention of skin-resident memory T(H)17 cells. Sci Immunol. 2022;7:eabq3254.","journal-title":"Sci Immunol"},{"key":"7446_CR14","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jaci.2023.11.017","volume":"153","author":"L Migayron","year":"2024","unstructured":"Migayron L, Merhi R, Seneschal J, Boniface K. Resident memory T cells in nonlesional skin and healed lesions of patients with chronic inflammatory diseases: appearances can be deceptive. J Allergy Clin Immunol. 2024;153:606\u201314.","journal-title":"J Allergy Clin Immunol"},{"key":"7446_CR15","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.4049\/jimmunol.1302313","volume":"192","author":"S Cheuk","year":"2014","unstructured":"Cheuk S, Wiken M, Blomqvist L, Nylen S, Talme T, Stahle M, Eidsmo L. Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis. The J Immunol. 2014;192:3111\u201320.","journal-title":"The J Immunol"},{"key":"7446_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12964-023-01381-0","volume":"22","author":"S Liu","year":"2024","unstructured":"Liu S, He M, Jiang J, Duan X, Chai B, Zhang J, Tao Q, Chen H. Triggers for the onset and recurrence of psoriasis: a review and update. Cell Commun Signal. 2024;22:108.","journal-title":"Cell Commun Signal"},{"key":"7446_CR17","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/s41385-018-0017-4","volume":"11","author":"D Lapuente","year":"2018","unstructured":"Lapuente D, Storcksdieck Genannt Bonsmann M, Maaske A, Stab V, Heinecke V, Watzstedt K, Hess R, Westendorf AM, Bayer W, Ehrhardt C, Tenbusch M. IL-1beta as mucosal vaccine adjuvant: the specific induction of tissue-resident memory T cells improves the heterosubtypic immunity against influenza a viruses. Mucosal Immunol. 2018;11:1265\u201378.","journal-title":"Mucosal Immunol"},{"key":"7446_CR18","doi-asserted-by":"crossref","unstructured":"Fenix K, Wijesundara DK, Cowin AJ, Grubor-Bauk B, Kopecki Z. Immunological memory in imiquimod-induced murine Model of psoriasiform dermatitis. Int J Mol Sci. 2020;21.","DOI":"10.3390\/ijms21197228"},{"key":"7446_CR19","doi-asserted-by":"publisher","first-page":"10466","DOI":"10.7150\/thno.45211","volume":"10","author":"Y Chen","year":"2020","unstructured":"Chen Y, Yan Y, Liu H, Qiu F, Liang CL, Zhang Q, Huang RY, Han L, Lu C, Dai Z. Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8(+) T-cell memory in wild-type and humanized mice. Theranostics. 2020;10:10466\u201382.","journal-title":"Theranostics"},{"key":"7446_CR20","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/art.38305","volume":"66","author":"JS Park","year":"2014","unstructured":"Park JS, Kwok SK, Lim MA, Kim EK, Ryu JG, Kim SM, Oh HJ, Ju JH, Park SH, Kim HY, Cho ML. STA-21, a promising STAT-3 inhibitor that reciprocally regulates Th17 and Treg cells, inhibits osteoclastogenesis in mice and humans and alleviates autoimmune inflammation in an experimental model of rheumatoid arthritis. Arthritis Rheumatol. 2014;66:918\u201329.","journal-title":"Arthritis Rheumatol"},{"key":"7446_CR21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/jid.2010.255","volume":"131","author":"K Miyoshi","year":"2011","unstructured":"Miyoshi K, Takaishi M, Nakajima K, Ikeda M, Kanda T, Tarutani M, Iiyama T, Asao N, DiGiovanni J, Sano S. Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor. The J Invest Dermatol. 2011;131:108\u201317.","journal-title":"The J Invest Dermatol"},{"key":"7446_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jid.2023.06.194","volume":"144","author":"JE Kim","year":"2024","unstructured":"Kim JE, Lee J, Huh YJ, Kim K, Chaparala V, Krueger JG, Kim J. Genomic profiling of the overlap phenotype between psoriasis and atopic dermatitis. The J Invest Dermatol. 2024;144:43\u201352 e46.","journal-title":"The J Invest Dermatol"},{"key":"7446_CR23","doi-asserted-by":"publisher","first-page":"110283","DOI":"10.1016\/j.clim.2024.110283","volume":"265","author":"J Soul","year":"2024","unstructured":"Soul J, Carlsson E, Hofmann SR, Russ S, Hawkes J, Schulze F, Sergon M, Pablik J, Abraham S, Hedrich CM. Tissue gene expression profiles and communication networks inform candidate blood biomarker identification in psoriasis and atopic dermatitis. Clin Immunol. 2024;265:110283.","journal-title":"Clin Immunol"},{"key":"7446_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fimmu.2014.00058","volume":"5","author":"B Carow","year":"2014","unstructured":"Carow B, Rottenberg ME. SOCS3, a Major regulator of infection and inflammation. Front Immunol. 2014;5:58.","journal-title":"Front Immunol"},{"key":"7446_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/cmi.2013.36","volume":"11","author":"JK Chhabra","year":"2014","unstructured":"Chhabra JK, Chattopadhyay B, Paul BN. SOCS3 dictates the transition of divergent time-phased events in granulocyte TNF-alpha signaling. Cell Mol Immunol. 2014;11:105\u201306.","journal-title":"Cell Mol Immunol"},{"key":"7446_CR26","doi-asserted-by":"publisher","first-page":"eabn1889","DOI":"10.1126\/sciimmunol.abn1889","volume":"7","author":"TR Matos","year":"2022","unstructured":"Matos TR, Gehad A, Teague JE, Dyring-Andersen B, Benezeder T, Dowlatshahi M, Crouch J, Watanabe Y, O\u2019Malley JT, Kupper TS, et al. Central memory T cells are the most effective precursors of resident memory T cells in human skin. Sci Immunol. 2022;7:eabn1889.","journal-title":"Sci Immunol"},{"key":"7446_CR27","doi-asserted-by":"crossref","unstructured":"Toth KA, Schmitt EG, Kolicheski A, Greenberg ZJ, Levendosky E, Saucier N, Trammel K, Oikonomou V, Lionakis MS, Klechevsky E, et al. A human STAT3 gain-of-function variant drives local Th17 dysregulation and skin inflammation in mice. J Exp Med. 2024;221.","DOI":"10.1084\/jem.20232091"},{"key":"7446_CR28","doi-asserted-by":"crossref","unstructured":"Ravipati A, Nolan S, Alphonse M, Dikeman D, Youn C, Wang Y, Orlando N, Patrick G, Lee S, Ortines RV, et al. IL-6R\/Signal transducer and activator of transcription 3 signaling in keratinocytes rather than in T cells induces psoriasis-like dermatitis in mice. The J Invest Dermatol. 2022;142:1126\u201335 e1124.","DOI":"10.1016\/j.jid.2021.09.012"},{"key":"7446_CR29","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41420-023-01575-y","volume":"9","author":"M Zhang","year":"2023","unstructured":"Zhang M, Meng Y, Ying Y, Zhou P, Zhang S, Fang Y, Yao Y, Li D. Selective activation of STAT3 and STAT5 dictates the fate of myeloid progenitor cells. Cell Death Discov. 2023;9:274.","journal-title":"Cell Death Discov"},{"key":"7446_CR30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","volume":"23","author":"KHG Mills","year":"2023","unstructured":"Mills KHG. IL-17 and IL-17-producing cells in protection versus pathology. Nat Rev Immunol. 2023;23:38\u201354.","journal-title":"Nat Rev Immunol"},{"key":"7446_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou X, Chen Y, Cui L, Shi Y, Guo C. Advances in the pathogenesis of psoriasis: from keratinocyte perspective. Cell Death Dis. 2022;13:81.","journal-title":"Cell Death Dis"},{"key":"7446_CR32","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/ni.3099","volume":"16","author":"R Basu","year":"2015","unstructured":"Basu R, Whitley SK, Bhaumik S, Zindl CL, Schoeb TR, Benveniste EN, Pear WS, Hatton RD, Weaver CT. IL-1 signaling modulates activation of stat transcription factors to antagonize retinoic acid signaling and control the TH17 cell-iTreg cell balance. Nat Immunol. 2015;16:286\u201395.","journal-title":"Nat Immunol"},{"key":"7446_CR33","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/ni.3105","volume":"16","author":"AV Villarino","year":"2015","unstructured":"Villarino AV, Laurence A. IL-1 watches the watchmen. Nat Immunol. 2015;16:226\u201327.","journal-title":"Nat Immunol"},{"key":"7446_CR34","doi-asserted-by":"publisher","first-page":"e695","DOI":"10.1002\/iid3.695","volume":"10","author":"M Ozcep","year":"2022","unstructured":"Ozcep M, Atsu N, Solak N, Celik SK. Lack of association between SOCS3 and SOCS7 polymorphisms and psoriasis. Immun Inflamm Dis. 2022;10:e695.","journal-title":"Immun Inflamm Dis"},{"key":"7446_CR35","doi-asserted-by":"publisher","first-page":"1393799","DOI":"10.3389\/fimmu.2024.1393799","volume":"15","author":"M Morelli","year":"2024","unstructured":"Morelli M, Madonna S, Albanesi C. SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation. Front Immunol. 2024;15:1393799.","journal-title":"Front Immunol"},{"key":"7446_CR36","doi-asserted-by":"publisher","first-page":"e40343","DOI":"10.1371\/journal.pone.0040343","volume":"7","author":"A Uto-Konomi","year":"2012","unstructured":"Uto-Konomi A, Miyauchi K, Ozaki N, Motomura Y, Suzuki Y, Yoshimura A, Suzuki S, Cua D, Kubo M. Dysregulation of suppressor of cytokine signaling 3 in keratinocytes causes skin inflammation mediated by interleukin-20 receptor-related cytokines. PLoS One. 2012;7:e40343.","journal-title":"PLoS One"},{"key":"7446_CR37","doi-asserted-by":"publisher","first-page":"652846","DOI":"10.3389\/fimmu.2021.652846","volume":"12","author":"P Martin","year":"2021","unstructured":"Martin P, Goldstein JD, Mermoud L, Diaz-Barreiro A, Palmer G. IL-1 family antagonists in mouse and human skin inflammation. Front Immunol. 2021;12:652846.","journal-title":"Front Immunol"},{"key":"7446_CR38","doi-asserted-by":"publisher","first-page":"H776","DOI":"10.1152\/ajpheart.00570.2012","volume":"304","author":"K Dhar","year":"2013","unstructured":"Dhar K, Rakesh K, Pankajakshan D, Agrawal DK. SOCS3 promotor hypermethylation and STAT3-NF-kappaB interaction downregulate SOCS3 expression in human coronary artery smooth muscle cells. Am J Physiol Heart Circ Physiol. 2013;304:H776\u2013785.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"7446_CR39","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/j.jid.2021.01.005","volume":"141","author":"H Mehta","year":"2021","unstructured":"Mehta H, Mashiko S, Angsana J, Rubio M, Hsieh YM, Maari C, Reich K, Blauvelt A, Bissonnette R, Munoz-Elias EJ, Sarfati M. Differential changes in inflammatory mononuclear phagocyte and T-Cell profiles within psoriatic skin during treatment with Guselkumab vs. Secukinumab. J Invest Dermatol. 2021;141:1707\u201318 e1709.","journal-title":"Secukinumab. J Invest Dermatol"},{"key":"7446_CR40","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.jaci.2022.12.823","volume":"151","author":"SH Kim","year":"2023","unstructured":"Kim SH, Oh J, Roh WS, Park J, Chung KB, Lee GH, Lee YS, Kim JH, Lee HK, Lee H, et al. Pellino-1 promotes intrinsic activation of skin-resident IL-17A-producing T cells in psoriasis. J Allergy Clin Immunol. 2023;151:1317\u201328.","journal-title":"J Allergy Clin Immunol"},{"key":"7446_CR41","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1016\/j.jaci.2020.11.028","volume":"147","author":"J Liu","year":"2021","unstructured":"Liu J, Chang HW, Huang ZM, Nakamura M, Sekhon S, Ahn R, Munoz-Sandoval P, Bhattarai S, Beck KM, Sanchez IM, et al. Single-cell rna sequencing of psoriatic skin identifies pathogenic Tc17 cell subsets and reveals distinctions between CD8(+) T cells in autoimmunity and cancer. J Allergy Clin Immunol. 2021;147:2370\u201380.","journal-title":"J Allergy Clin Immunol"},{"key":"7446_CR42","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1126\/science.adi8885","volume":"382","author":"SL Park","year":"2023","unstructured":"Park SL, Christo SN, Wells AC, Gandolfo LC, Zaid A, Alexandre YO, Burn TN, Schroder J, Collins N, Han SJ, et al. Divergent molecular networks program functionally distinct CD8(+) skin-resident memory T cells. Science. 2023;382:1073\u201379.","journal-title":"Science"},{"key":"7446_CR43","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.it.2008.07.002","volume":"29","author":"H Kelchtermans","year":"2008","unstructured":"Kelchtermans H, Billiau A, Matthys P. How interferon-gamma keeps autoimmune diseases in check. Trends Immunol. 2008;29:479\u201386.","journal-title":"Trends Immunol"},{"key":"7446_CR44","doi-asserted-by":"publisher","first-page":"11495","DOI":"10.1073\/pnas.1002099107","volume":"107","author":"G Murugaiyan","year":"2010","unstructured":"Murugaiyan G, Mittal A, Weiner HL. Identification of an IL-27\/osteopontin axis in dendritic cells and its modulation by IFN-gamma limits IL-17-mediated autoimmune inflammation. Proc Natl Acad Sci U S A. 2010;107:11495\u2013500.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7446_CR45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jneuroim.2013.12.001","volume":"267","author":"WI Yeh","year":"2014","unstructured":"Yeh WI, Il M, Harrington LE. Ifngamma inhibits Th17 differentiation and function via Tbet-dependent and Tbet-independent mechanisms. J Neuroimmunol. 2014;267:20\u201327.","journal-title":"J Neuroimmunol"},{"key":"7446_CR46","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/path.4887","volume":"242","author":"M Bernard","year":"2017","unstructured":"Bernard M, Carrasco C, Laoubi L, Guiraud B, Rozieres A, Goujon C, Duplan H, Bessou-Touya S, Nicolas JF, Vocanson M, Galliano MF. IL-1beta induces thymic stromal lymphopoietin and an atopic dermatitis-like phenotype in reconstructed healthy human epidermis. The J Pathol. 2017;242:234\u201345.","journal-title":"The J Pathol"},{"key":"7446_CR47","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1111\/exd.14323","volume":"30","author":"S Blunder","year":"2021","unstructured":"Blunder S, Krimbacher T, Moosbrugger-Martinz V, Gruber R, Schmuth M, Dubrac S. Keratinocyte-derived IL-1beta induces PPARG downregulation and ppard upregulation in human reconstructed epidermis following barrier impairment. Exp Dermatol. 2021;30:1298\u2013308.","journal-title":"Exp Dermatol"},{"key":"7446_CR48","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.jaci.2023.07.010","volume":"152","author":"E Guttman-Yassky","year":"2023","unstructured":"Guttman-Yassky E, Irvine AD, Brunner PM, Kim BS, Boguniewicz M, Parmentier J, Platt AM, Kabashima K. The role of Janus kinase signaling in the pathology of atopic dermatitis. J Allergy Clin Immunol. 2023;152:1394\u2013404.","journal-title":"J Allergy Clin Immunol"},{"key":"7446_CR49","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jaci.2024.05.008","volume":"154","author":"L Francis","year":"2024","unstructured":"Francis L, Capon F, Smith CH, Haniffa M, Mahil SK. Inflammatory memory in psoriasis: from remission to recurrence. J Allergy Clin Immunol. 2024;154:42\u201350.","journal-title":"J Allergy Clin Immunol"},{"key":"7446_CR50","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jdermsci.2022.02.008","volume":"105","author":"K Kurihara","year":"2022","unstructured":"Kurihara K, Fujiyama T, Phadungsaksawasdi P, Ito T, Honda T, Tokura Y. Epidermal CD8(+)CD103(+) skin resident memory T cells in psoriasis plaques are reduced in number but remain in the basement membrane zone after topical application of corticosteroid and vitamin D3. J Dermatol Sci. 2022;105:192\u201394.","journal-title":"J Dermatol Sci"},{"key":"7446_CR51","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.jid.2019.09.027","volume":"140","author":"S Mashiko","year":"2020","unstructured":"Mashiko S, Edelmayer RM, Bi Y, Olson LM, Wetter JB, Wang J, Maari C, Saint-Cyr Proulx E, Kaimal V, Li X, et al. Persistence of inflammatory phenotype in residual psoriatic plaques in patients on effective biologic therapy. The J Invest Dermatol. 2020;140:1015\u201325 e1014.","journal-title":"The J Invest Dermatol"},{"key":"7446_CR52","doi-asserted-by":"publisher","first-page":"111344","DOI":"10.1016\/j.intimp.2023.111344","volume":"127","author":"C Ti","year":"2024","unstructured":"Ti C, Chen H, Zhou W, Bian A, Hu P, Miao Y, Shao T, Liu M, Chen Y, Yi Z. WB518, a novel STAT3 inhibitor, effectively alleviates IMQ and TPA-induced animal psoriasis by inhibiting STAT3 phosphorylation and keratin 17. Int Immunopharmacol. 2024;127:111344.","journal-title":"Int Immunopharmacol"},{"key":"7446_CR53","doi-asserted-by":"publisher","first-page":"116167","DOI":"10.1016\/j.biopha.2024.116167","volume":"171","author":"J Wu","year":"2024","unstructured":"Wu J, Li L, Zhu Q, Zhang T, Miao F, Cui Z, Dong G, Tai Z, Chen Z. JAK1\/JAK2 degraders based on protac for topical treatment of atopic dermatitis. Biomed Pharmacother. 2024;171:116167.","journal-title":"Biomed Pharmacother"},{"key":"7446_CR54","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41419-025-07535-x","volume":"16","author":"S Li","year":"2025","unstructured":"Li S, Wang X, Huang J, Cao X, Liu Y, Bai S, Zeng T, Chen Q, Li C, Lu C, Yang H. Decoy-PROTAC for specific degradation of \u201cundruggable\u201d STAT3 transcription factor. Cell Death Dis. 2025;16:197.","journal-title":"Cell Death Dis"},{"key":"7446_CR55","doi-asserted-by":"publisher","first-page":"6904","DOI":"10.1021\/acsnano.8b02330","volume":"12","author":"JY Kim","year":"2018","unstructured":"Kim JY, Ahn J, Kim J, Choi M, Jeon H, Choe K, Lee DY, Kim P, Jon S. Nanoparticle-assisted transcutaneous delivery of a signal transducer and activator of transcription 3-inhibiting peptide ameliorates psoriasis-like skin inflammation. ACS Nano. 2018;12:6904\u201316.","journal-title":"ACS Nano"},{"key":"7446_CR56","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/s41590-025-02149-z","volume":"26","author":"R Cineus","year":"2025","unstructured":"Cineus R, Luo Y, Saliutina M, Manna S, Cancino CA, Velasco Blazquez L, Wang L, Bosel D, Abdelrahman A, Klementowicz JE, et al. The IL-22-oncostatin M axis promotes intestinal inflammation and tumorigenesis. Nat Immunol. 2025;26:837\u201353.","journal-title":"Nat Immunol"},{"key":"7446_CR57","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1016\/j.cmet.2024.08.012","volume":"36","author":"P Zhang","year":"2024","unstructured":"Zhang P, Liu J, Lee A, Tsaur I, Ohira M, Duong V, Vo N, Watari K, Su H, Kim JY, et al. IL-22 resolves MASLD via enterocyte STAT3 restoration of diet-perturbed intestinal homeostasis. Cell Metab. 2024;36:2341\u201354 e2346.","journal-title":"Cell Metab"},{"key":"7446_CR58","doi-asserted-by":"publisher","first-page":"1516068","DOI":"10.3389\/fimmu.2025.1516068","volume":"16","author":"R AlYafie","year":"2025","unstructured":"AlYafie R, Velayutham D, van Panhuys N, Jithesh PV. The genetics of hyper IgE syndromes. Front Immunol. 2025;16:1516068.","journal-title":"Front Immunol"},{"key":"7446_CR59","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1158\/1078-0432.CCR-24-2920","volume":"31","author":"AM Tsimberidou","year":"2025","unstructured":"Tsimberidou AM, Vining DJ, Arora SP, de Achaval S, Larson J, Kauh J, Cartwright C, Avritscher R, Alibhai I, Tweardy DJ, Kaseb AO. Phase I trial of TTI-101, a first-in-class oral inhibitor of STAT3, in patients with advanced solid tumors. Clin Cancer Res. 2025;31:965\u201374.","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07446-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07446-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07446-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T03:03:56Z","timestamp":1768359836000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07446-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7446"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07446-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7432855\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"22 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were approved by the Institutional Animal Care and Use Committee (IACUC), Department of Laboratory Animals, College of Medicine, Catholic University of Korea, and complied with the guidelines of the National Institutes of Health. (Permit Number: 2023\u20130110\u201304). And all procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. (KC17TNSI0237, KC25SISI0528).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors declare that they have no conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors have given their consent for the publication of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"60"}}